Journey Medical Corporation

Journey Medical Corporation

$5.24
0.05 (0.96%)
NASDAQ Capital Market
USD, US
Drug Manufacturers - Specialty & Generic

DERM Price Chart

Basic
Market Cap$109.46M
Price$5.24
52 Week Range2.85-6.89
Beta1.04
Margins
Gross Profit Margin62.81%
Operating Profit Margin-24.36%
Net Profit Margin-26.14%
Valuation (TTM)
P/E Ratio-10.01
Price to Sales Ratio2.96
Price to Book Ratio7.32
PEG Ratio-0.52

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Full-Time Employees

41

IPO Date

2021-11-12T00:00:00.000Z

Description

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Phone

480 434 6670

Address

9237 East Via de Ventura Boulevard, Scottsdale, AZ, 85258, US

CIK

0001867066